JAMES L. SHERLEY, identified by the Globe as a stem cell biologist at Massachusetts Institute of Technology and a Harvard graduate, has written a critique of Harvard's initiative to clone embryonic stem cells for medical purposes (" Crossing line on cloning ," op-ed, June 12). For several paragraphs, he insists that the proposed research is a dead end, and will ... (Full article: 434 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
